If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...

Pfizer’s “golden egg” has hatched. The subcutaneous PD-1 inhibitor improved outcomes when added to the standard of care in ...

It’s the first major partnership for Janux, which was set up in 2017, and could be the last to be organised by Merck’s R&D head Roger Perlmutter who is retiring from the big pharma company at ...

Merck & Co is pressing home its precious advantage in first line non-small cell lung cancer, with new data from a Keytruda + chemo combination suggesting patients' lives could be significantly ...

The media will focus on a handful of pop acts when the true action will be in smaller acts outside the national consciousness ...

Two Lonaconing families were left homeless late Wednesday when fire swept through their duplex at 11-13 Church St., according to the Maryland State Fire Marshal's Office. The Michael Ashby family that ...

Menards stores across the country are serving as drop-off sites for local food pantries this winter. Each store has picked a local charity in their community to benefit from the food drive. Sam Martin ...

Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair (sotatercept) for adult patients with pulmonary arterial hypertension (PAH).

The Chinese contract drugmaker will sell its vaccine factory in Dundalk, Ireland, to U.S.-based Merck for about $500 million, it said in an exchange filing late Monday. The facility, with a net ...

Merck wins UK approval for lung disease drug acquired in $11 billion deal Future of Healthcategory· December 31, 2024 The U.S. Food and Drug Administration said on Friday that it has approved an ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...